{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-023723","form_type":"8-K","ticker":null,"cik":"0001401395","company_name":"Neptune Wellness Solutions Inc.","filed_at":"2022-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.457818+00:00","generated_at":"2026-06-22T01:00:36.631597+00:00","sec_items":["2.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Neptune Wellness completes $5.15M divestiture of cannabis assets to PurCann Pharma","bullets":["Completed sale of cannabis business for $5.15M cash to PurCann Pharma, Inc.","Assets divested include Sherbrooke, Québec processing plant, Mood Ring and PanHash brands.","Marks key step in strategy to become a leading pure-play CPG company centered on Sprout brand.","Expects to realize significant cost savings and operational streamlining from redirected resources."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-023723","json":"https://secwatch.observer/filing/0000950170-22-023723.json","markdown":"https://secwatch.observer/filing/0000950170-22-023723.md","text":"https://secwatch.observer/filing/0000950170-22-023723.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401395/000095017022023723/0000950170-22-023723-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401395/000095017022023723/nept-20221109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T01:00:36.631597+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"370fc4b85da71ef6e2c97e2c299a1da282018d4f","claim":"Neptune Wellness Solutions Inc. completed a disposition involving PurCann Pharma, Inc. for $5,150,000 (closed 2022-11-09).","evidence_excerpt":"dated as of October 16, 2022, entered into with PurCann Pharma, Inc. (“Purchaser”). Pursuant to the Purchase Agreement, Purchaser paid the Company an aggregate purchase price of $5,150,000. The description above is a summary of the Purchase Agreement and the transactions contemplated thereby and is subject to, and qualified in its entirety by, reference to the full","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1401395/000095017022023723/0000950170-22-023723-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"disposition"},{"label":"Counterparty","value":"PurCann Pharma, Inc."},{"label":"Consideration","value":"$5,150,000"},{"label":"Closing","value":"2022-11-09"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}